Kevin McKernan

If you look at some of Pfizer's, that other publication I was mentioning where they were kind of bragging about how they grabbed gene therapy plasmids, they were making multiple plasmids in parallel to figure out which one would eventually end up in their product. And it's possible that some of their products are contaminated with the other ones.

If you look at some of Pfizer's, that other publication I was mentioning where they were kind of bragging about how they grabbed gene therapy plasmids, they were making multiple plasmids in parallel to figure out which one would eventually end up in their product. And it's possible that some of their products are contaminated with the other ones.

If you look at some of Pfizer's, that other publication I was mentioning where they were kind of bragging about how they grabbed gene therapy plasmids, they were making multiple plasmids in parallel to figure out which one would eventually end up in their product. And it's possible that some of their products are contaminated with the other ones.

I have a hunch that that might be the case just based on the sequence that we got from this colon cancer was not identical to the sequence we've seen in their vials. There are some differences there that are probably very material as to why this one is at such high copy number in those cancer patients. But that's yet to be published information.

I have a hunch that that might be the case just based on the sequence that we got from this colon cancer was not identical to the sequence we've seen in their vials. There are some differences there that are probably very material as to why this one is at such high copy number in those cancer patients. But that's yet to be published information.

I have a hunch that that might be the case just based on the sequence that we got from this colon cancer was not identical to the sequence we've seen in their vials. There are some differences there that are probably very material as to why this one is at such high copy number in those cancer patients. But that's yet to be published information.

We're still trying to get that sequence in other tissues to confirm it.

We're still trying to get that sequence in other tissues to confirm it.

We're still trying to get that sequence in other tissues to confirm it.

Yeah, this person was 4X vaccinated. Four times, wow.

Yeah, this person was 4X vaccinated. Four times, wow.

Yeah, this person was 4X vaccinated. Four times, wow.

All right. That's a couple of points there. So this patient is deceased, unfortunately. A year after vaccination, they got their first biopsy. A week after that, they got another biopsy. And then in four weeks, they were dead. And they got a postmortem biopsy as well. We sequenced the postmortem in the first one. and we're looking at the differences between those two.

All right. That's a couple of points there. So this patient is deceased, unfortunately. A year after vaccination, they got their first biopsy. A week after that, they got another biopsy. And then in four weeks, they were dead. And they got a postmortem biopsy as well. We sequenced the postmortem in the first one. and we're looking at the differences between those two.

All right. That's a couple of points there. So this patient is deceased, unfortunately. A year after vaccination, they got their first biopsy. A week after that, they got another biopsy. And then in four weeks, they were dead. And they got a postmortem biopsy as well. We sequenced the postmortem in the first one. and we're looking at the differences between those two.

There is a plasmid in there that codes for spike. The sequence of that spike is a little different. It's a lot different than the spike that Pfizer has in the vaccines we've sequenced previously. So this has raised a question as to what is really the source of this plasmid, because the differences there have raised alarm bells. It's not exactly what we saw.

There is a plasmid in there that codes for spike. The sequence of that spike is a little different. It's a lot different than the spike that Pfizer has in the vaccines we've sequenced previously. So this has raised a question as to what is really the source of this plasmid, because the differences there have raised alarm bells. It's not exactly what we saw.

There is a plasmid in there that codes for spike. The sequence of that spike is a little different. It's a lot different than the spike that Pfizer has in the vaccines we've sequenced previously. So this has raised a question as to what is really the source of this plasmid, because the differences there have raised alarm bells. It's not exactly what we saw.

Now, we've only sequenced two other lots before, So we don't have good surveillance of all the different lots of Pfizer. They could have different plasmids in each one. They could all be the same. We don't know. We need to do more to sort that out. But there is another hypothesis that could be at play here that leads to a much more frightening scenario, I think, in my mind, which is –

Now, we've only sequenced two other lots before, So we don't have good surveillance of all the different lots of Pfizer. They could have different plasmids in each one. They could all be the same. We don't know. We need to do more to sort that out. But there is another hypothesis that could be at play here that leads to a much more frightening scenario, I think, in my mind, which is –